Literature DB >> 6121691

Testing antisecretory drugs in Zollinger-Ellison syndrome: problems and limits in pharmacological studies.

S Bonfils.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6121691     DOI： 10.1007/bf01296762

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  3 in total

1.  Pathophysiological responses to meals in the Zollinger-Ellison syndrome: I. Paradoxical postprandial inhibition of gastric secretion.

Authors:  J R Malagelada
Journal:  Gut       Date:  1978-04       Impact factor: 23.059

2.  Improved technique of gastric aspiration.

Authors:  R M Hector
Journal:  Lancet       Date:  1968-01-06       Impact factor: 79.321

3.  Interest of a combined antisecretory treatment, cimetidine and pirenzepin, in the management of severe forms of Zollinger-Ellison syndrome.

Authors:  M Mignon; T Vallot; J P Galmiche; J L Dupas; S Bonfils
Journal:  Digestion       Date:  1980       Impact factor: 3.216
  3 in total
  1 in total

1.  Evaluation of antisecretory drug therapy of Zollinger-Ellison syndrome (ZES) using 24-hour pH monitoring.

Authors:  T Vallot; M Mignon; R Mazure; S Bonfils
Journal:  Dig Dis Sci       Date:  1983-07       Impact factor: 3.199
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.